CAS 355151-12-1

(2R,4S)-1-(Acetyl-D-tyrosyl-D-prolyl)-N-(2-(((R)-1-((2-amino-2-oxoethyl)amino)-1-oxopropan-2-yl)amino)-2-oxoethyl)-4-hydroxypyrrolidine-2-carboxamide

CAS : 355151-12-1

(2R,4S)-1-(Acetyl-D-tyrosyl-D-prolyl)-N-(2-(((R)-1-((2-amino-2-oxoethyl)amino)-1-oxopropan-2-yl)amino)-2-oxoethyl)-4-hydroxypyrrolidine-2-carboxamide

Degré de pureté : 99%

Masse moléculaire : 617.66g/mol

Ref: 54-OR1074612

Rotigaptide

CAS : 355151-12-1

Rotigaptide, modulates Cx43 for gap junctions, counteracts uncoupling, and maintains communication under stress.

Formule : C₂₈H₃₉N₇O₉

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 617.65

Ref: TM-T16790

Rotigaptide

CAS : 355151-12-1

Rotigaptide is a synthetic peptide that has been shown to inhibit the activity of the cell factor, which is responsible for regulating the heart. This drug may be used in the treatment of congestive heart failure, as well as other cardiac disorders such as atrial and myocardial infarcts. Rotigaptide has been found to have pharmacological properties that are similar to those of angiotensin II or angiotensin converting enzyme (ACE) inhibitors. The drug also exhibits anti-platelet activity and may be useful in treating structural heart disease.

Degré de pureté : Min. 95%

Ref: 3D-FR176236

Rotigaptide

Produit contrôlé

CAS : 355151-12-1

Formule : C₂₈H₃₉N₇O₉

Couleur et forme : Neat

Masse moléculaire : 617.651

Ref: TR-R693525